SOTAVerified

Evening the Score: Targeting SARS-CoV-2 Protease Inhibition in Graph Generative Models for Therapeutic Candidates

2021-05-07Code Available1· sign in to hype

Jenna Bilbrey, Logan Ward, Sutanay Choudhury, Neeraj Kumar, Ganesh Sivaraman

Code Available — Be the first to reproduce this paper.

Reproduce

Code

Abstract

We examine a pair of graph generative models for the therapeutic design of novel drug candidates targeting SARS-CoV-2 viral proteins. Due to a sense of urgency, we chose well-validated models with unique strengths: an autoencoder that generates molecules with similar structures to a dataset of drugs with anti-SARS activity and a reinforcement learning algorithm that generates highly novel molecules. During generation, we explore optimization toward several design targets to balance druglikeness, synthetic accessability, and anti-SARS activity based on . This generative frameworkhttps://github.com/exalearn/covid-drug-design will accelerate drug discovery in future pandemics through the high-throughput generation of targeted therapeutic candidates.

Tasks

Reproductions